The Routledge International Handbook of Drug-Related Death Bereavement
Routledge (Verlag)
978-1-032-31310-8 (ISBN)
This handbook provides a comprehensive overview of drug-related death bereavement to increase understanding and help direct scientific research, with contributions from across the globe.
It is the first comprehensive, cross-cultural, multidisciplinary review of research on drug-related death (DRD)bereavement. Chapters cover the impact of DRD at individual, family, cultural, and societal levels, and topics include working with, and social support for, families following drug-related loss, understanding grief processes of individuals, drug policy, and the importance of cultural contexts. The book also elaborates on methodological issues when researching DRD.
This handbook will increase understanding of DRD bereavement and contribute to support for DRD bereaved persons and those who care for them professionally and personally. It is essential reading for professionals and academics in the field as well as anyone affected by DRD.
Margaret Stroebe, PhD, is Professor Emerita and continuing visiting professor at the Department of Clinical Psychology, Utrecht University, and the Department of Clinical Psychology & Experimental Psychopathology, University of Groningen, Netherlands. Kari Dyregrov, PhD, is Professor Emerita and continuing at the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway. Kristine Berg Titlestad, PhD, is an associate professor at the Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
PART I. SETTING THE STAGE
1. Introduction to the Handbook
Margaret Stroebe, Kari Dyregrov and Kristine B. Titlestad
2. Researching drug-related death bereavement: Methodological suggestions for the study of key conceptual issues
Eleftheria Tseliou and Georgios Abakoumkin
3. Drug-related death bereavement: Commentary by a bereaved parent on a research study
Kelly Thomas, Kristine B. Titlestad, Margaret Stroebe, and Kari Dyregrov
PART II. CONTEXT: THE SOCIETAL EMBEDDEDNESS OF BEREAVEMENT FOLLOWING A DRUG-RELATED DEATH
4. The importance of cultural context: A cross-cultural perspective on drug-death bereavement
Paul C. Rosenblatt
5. Drug policy and welfare systems as context for drug-related death bereavement
Svanaug Fjær and Kari Dyregrov
6. Disenfranchisement following a drug-related death
Kenneth J. Doka and Kari Dyregrov
7. The impact of stigmatization before and after drug-related deaths
Beatrice M. Wendeln, Madeline Oppenheim, Georg Schomerus, Patrick W. Corrigan
PART III. CONSEQUENCES AND COPING (1): THE BEREAVEMENT EXPERIENCE FOLLOWING A DRUG-RELATED DEATH
8. Bereaved parents’ relationship following drug-related death loss: (What) can we learn from relationship research?
Asuman Buyukcan-Tetik, Catrin Finkenauer, and Sara Albuquerque
9. Understanding parental grief on the death of a child who used narcotics
William T. Feigelman and Kristine B. Titlestad
10. Risk factors for prolonged grief disorder in people bereaved by drug-related deaths
Øyvind R. Kalsås and Maja O’Connor
11. Adjusting to loss after death from drug-related versus other traumatic deaths: Unique challenges?
Jamison S. Bottomley, William T. Feigelman, and Alyssa A. Rheingold
12. Coping with bereavement due to drug-related death in the context of one’s own drug challenges
Richard Velleman and Lillian Bruland Selseng
13. Patterns of coping following a drug-related death: An overview of the END project findings
Kristine B. Titlestad, Lillian B. Selseng and Kari Dyregrov
PART IV. CONSEQUENCES AND COPING (2): BEYOND THE WESTERN WORLD
14. Dealing with bereavement following a drug-related death in China
Xinxian Liu and Suqin Tang
15. "Sℇ Asa”: Bereavement following bad deaths in Ghana
Johnny Andoh-Arthur
16. Bereavement following a drug-related death in Mexico and India
Richard Velleman, Marcela Tiburcio and Abhijit Nadkarni
PART V. CARE (1): SUPPORTING BEREAVED PERSONS FOLLOWING A DRUG-RELATED DEATH
17. Guidance for supporting/counselling people bereaved through a drug-related death: Unique circumstances, special needs
Peter Cartwright
18. Working with families following drug-death related loss
Sari Lindeman and Lillian B. Selseng
19. On the provision of informal and formal support: From personal networks and colleagues, to schools, front line and health care providers
Kari Dyregrov, Monika Reime and Sonja Mellingen
20. Stigma, kindness and professionalism: On fostering compassion and countering stigmatization
Richard Velleman and Lorna Templeton
21. Belonging and empowerment: Experiences of community support following a drug-related death
Joshua Stout and Benjamin Fleury-Steiner
22. Wall of Silence: Supporting providers after a drug-related death
Adelya A. Urmanche and Kate Szymanski
PART VI. CARE (2): TREATMENTS FOR DRUG-RELATED DEATH BEREAVED PERSONS IN NEED
23. Models of adaptation to bereavement: Application to grief therapy after a drug-related death
Jamison S. Bottomley and Robert A. Neimeyer
24. Prolonged Grief Disorder therapy for drug-related death bereaved, with insights from the Dual Process Model
Henry Willis, Natalia Skritskaya, and M. Katherine Shear
25. Psychotherapeutic treatment for bereaved persons encountering grief difficulties following a drug-related death
Jens C. Thimm and Pål Kristensen
26. Brief Eclectic Psychotherapy for prolonged and traumatic grief following drug-related death
Geert Smid, Sophie M.C. Hengst, Joanna Wojtkowiak, Rebecca Gasser, and Paul A. Boelen
27. Structured support for adults bereaved by a drug-related death: The potential of the 5-Step Method
Lorna Templeton
28. Rebuilding relationships: The benefits of increasing self-awareness through writing following a drug-related death
Christina Thatcher
PART VII. REFLECTIONS
29. Implications of the END project: Beyond the Norwegian context?
Monika Reime, Lillian B. Selseng, Kristine B. Titlestad and Kari Dyregrov
30. The handbook under the magnifying glass: Lessons (still) to be learnt from the study of drug-
related death bereavement
Margaret Stroebe, Kari Dyregrov, and Kristine B. Titlestad
| Erscheinungsdatum | 23.03.2024 |
|---|---|
| Reihe/Serie | Routledge International Handbooks |
| Zusatzinfo | 9 Tables, black and white; 8 Line drawings, black and white; 8 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 174 x 246 mm |
| Gewicht | 907 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Suchtkrankheiten | |
| Sozialwissenschaften ► Pädagogik ► Sozialpädagogik | |
| Sozialwissenschaften ► Soziologie | |
| ISBN-10 | 1-032-31310-2 / 1032313102 |
| ISBN-13 | 978-1-032-31310-8 / 9781032313108 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
